Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Dose Regimens of MT-3724 with Gemzar and Oxaliplatin for the Treatment of Subjects with RElapsed or Refractory B Cell NonHodgkins Lymphoma (GEMOX+MT3724)
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Dose Regimens of MT-3724 with Gemzar and Oxaliplatin for the Treatment of Subjects with RElapsed or Refractory B Cell NonHodgkins Lymphoma (GEMOX+MT3724)
Trial Category:
Lymphoma
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
